Life-threatening hypophosphatemia in a patient with acute myelogenous leukemia.
A patient with acute myelogenous leukemia developed severe hypophosphatemia manifesting by extreme weakness, confusion, loss of sphincter control, nuchal rigidity, hyperesthesia, hemolysis, congestive heart failure and liver dysfunction. The possible causes for this condition were starvation, parenteral glucose and saline administration, sepsis, hypokalemia and treatment with acetazolamide. A dramatic improvement was noted following phosphate administration.
D000086:Acetazolamide / Q000009:adverse effects; D003561:Cytarabine / Q000627:therapeutic use; D003630:Daunorubicin / Q000627:therapeutic use; D005260:Female; D005947:Glucose / Q000008:administration & dosage; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000097:blood* / Q000188:drug therapy; D008875:Middle Aged; D010710:Phosphates / Q000097:blood* / Q000627:therapeutic use; D018805:Sepsis / Q000150:complications; D012965:Sodium Chloride / Q000008:administration & dosage; D013217:Starvation
D010710:Phosphates; D003561:Cytarabine; D012965:Sodium Chloride; D005947:Glucose; D000086:Acetazolamide; D003630:Daunorubicin